Earnings History Data for Design Therapeutics (DSGN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Design Therapeutics
Design Therapeutics Inc. is a biotechnology company. It involved in developing a platform of gene targeted chimera small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions. Design Therapeutics Inc. is based in CARLSBAD, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | DSGN | Design Therapeutics | 315.00 | -0.23 | -0.26 | 0.00 | Design Therapeutics GAAP EPS of -$0.23 beats by $0.02 [11/8/2024 8:44 AM] |
5.83 | 0.04 (0.61%) |
5.76 | -0.03 (-0.52%) |
1.96 - 6.91 | 141,407 | 90,000 | 6,073 | ||
| 05-08-2024 | PM | DSGN | Design Therapeutics | 285.00 | -0.21 | -0.25 | 0.00 | 4.65 | -0.09 (-1.90%) |
4.64 | -0.10 (-2.11%) |
1.94 - 7.83 | 134,539 | 240,000 | 804 | |||
|
|
||||||||||||||||||
| 08-05-2024 | AH | DSGN | Design Therapeutics | 206.00 | -0.20 | -0.28 | 0.00 | Design Therapeutics GAAP EPS of -$0.20 [5/9/2024 11:40 AM] |
4.79 | 0.10 (2.24%) |
5.04 | 0.35 (7.46%) |
1.94 - 8.47 | 437,995 | 430,000 | 3,009 | ||
| 19-03-2024 | AH | DSGN | Design Therapeutics, Inc. | 144.49 | -0.21 | 0.00 | -0.31 | Design Therapeutics GAAP EPS of -$0.21 beats by $0.11 [3/19/2024 4:07 PM] |
2.90 | 0.31 (11.78%) |
2.54 | -0.05 (-1.92%) |
1.94 - 8.47 | 383,534 | 160,000 | 1,756 | ||
| 13-11-2023 | PM | DSGN | Design Therapeutics | 111.00 | -0.28 | -0.42 | 0.00 | Design Therapeutics GAAP EPS of -$0.28 beats by $0.14 [11/14/2023 2:28 AM] |
2.29 | 0.24 (11.71%) |
2.12 | 0.07 (3.41%) |
1.94 - 16.38 | 1,445,678 | 320,000 | 300 | ||
| 14-03-2023 | AH | DSGN | Design Therapeutics | 363.00 | -0.31 | -0.34 | 0.00 | Design Therapeutics GAAP EPS of -$0.31 beats by $0.03 [3/14/2023 4:55 PM] |
7.02 | -0.05 (-0.71%) |
7.07 | 0.0 (0.00%) |
6.08 - 26.30 | 484,578 | 460,000 | 10,810 | ||
| 03-11-2022 | AH | 4:05 PM ET (Nov 3) |
DSGN | Design Therapeutics | 847.00 | -0.32 | -0.28 | 0.00 | Design Therapeutics GAAP EPS of -$0.32 misses by $0.04 [11/3/2022 5:38 PM] |
15.46 | -0.03 (-0.19%) |
15.49 | 0.0 (0.00%) |
9.61 - 26.30 | 301,850 | 280,000 | 5,717 | |
| 10-03-2022 | AH | DSGN | Design Therapeutics | 893.00 | -0.20 | -0.22 | 0.00 | Design Therapeutics GAAP EPS of -$0.20 [3/10/2022 5:27 PM] |
17.30 | -0.27 (-1.54%) |
17.57 | 0.0 (0.00%) |
10.37 - 50.50 | 65,644 | 150,000 | 632 | ||
|
||||||||||||||||||
| 09-11-2021 | AH | 4:05 PM ET (Nov 9) |
DSGN | Design Therapeutics, Inc. | 978.29 | -0.21 | -0.14 | 0.00 | Design Therapeutics EPS misses by $0.07 [11/9/2021 5:04 PM] |
18.88 | -0.03 (-0.19%) |
18.91 | 0.0 (0.00%) |
12.52 - 50.50 | 118,985 | 120,000 | 178 | |